Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Jan 2022
Historique:
received: 22 12 2021
revised: 09 01 2022
accepted: 11 01 2022
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 29 1 2022
Statut: epublish

Résumé

The global urgency to uncover medical countermeasures to combat the COVID-19 pandemic caused by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has revealed an unmet need for robust tissue culture models that faithfully recapitulate key features of human tissues and disease. Infection of the nose is considered the dominant initial site for SARS-CoV-2 infection and models that replicate this entry portal offer the greatest potential for examining and demonstrating the effectiveness of countermeasures designed to prevent or manage this highly communicable disease. Here, we test an air-liquid-interface (ALI) differentiated human nasal epithelium (HNE) culture system as a model of authentic SARS-CoV-2 infection. Progenitor cells (basal cells) were isolated from nasal turbinate brushings, expanded under conditionally reprogrammed cell (CRC) culture conditions and differentiated at ALI. Differentiated cells were inoculated with different SARS-CoV-2 clinical isolates. Infectious virus release into apical washes was determined by TCID

Identifiants

pubmed: 35055020
pii: ijms23020835
doi: 10.3390/ijms23020835
pmc: PMC8776210
pii:
doi:

Substances chimiques

ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : The Kim Wright Foundation
ID : N/A
Organisme : Doherty Collaborative Grant Scheme
ID : N/A

Références

Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
Prog Mol Biol Transl Sci. 2018 Jan;153:299-319
pubmed: 29389521
Viruses. 2021 May 27;13(6):
pubmed: 34071878
Adv Nanobiomed Res. 2021 May 06;1(6):
pubmed: 34345878
J Vis Exp. 2021 Nov 10;(177):
pubmed: 34842237
J Infect Dis. 2021 Sep 17;224(6):989-994
pubmed: 34260717
Nature. 2021 Nov 25;:
pubmed: 34823256
DNA Res. 2014 Dec;21(6):673-83
pubmed: 25267831
Nat Commun. 2021 Sep 17;12(1):5498
pubmed: 34535662
J Cyst Fibros. 2021 Mar;20(2):364-371
pubmed: 33414087
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
J Clin Med. 2020 Apr 28;9(5):
pubmed: 32353982
Dis Model Mech. 2021 Jun 1;14(6):
pubmed: 34219165
Cell Stem Cell. 2021 Jul 1;28(7):1205-1220.e7
pubmed: 34022129
Med J Aust. 2020 Jun;212(10):459-462
pubmed: 32237278
Nature. 2021 May;593(7860):492-494
pubmed: 34040221
JAMA. 2020 Mar 3;323(9):844-853
pubmed: 32125404
Elife. 2021 Jan 04;10:
pubmed: 33393462
Nat Rev Immunol. 2021 Oct;21(10):626-636
pubmed: 34373623
EMBO J. 2021 Mar 1;40(5):e105912
pubmed: 33283287
Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20035-40
pubmed: 23169653
Cell. 2016 Jun 16;165(7):1586-1597
pubmed: 27315476
Elife. 2021 Apr 09;10:
pubmed: 33835028
J Health Econ. 2016 May;47:20-33
pubmed: 26928437
Viruses. 2021 May 27;13(6):
pubmed: 34071855
Stem Cells Transl Med. 2021 Jul;10(7):976-986
pubmed: 33710758
Lab Invest. 1997 Apr;76(4):487-95
pubmed: 9111511
EMBO J. 2019 Feb 15;38(4):
pubmed: 30643021
Cell Stem Cell. 2020 Dec 3;27(6):890-904.e8
pubmed: 33128895
J Intern Med. 2021 May;289(5):604-613
pubmed: 32350962
Mod Pathol. 1997 Mar;10(3):192-9
pubmed: 9071726
N Engl J Med. 2020 Aug 6;383(6):517-525
pubmed: 32492293
Nat Med. 2021 Jul;27(7):1131-1133
pubmed: 34045737
Cell Discov. 2020 Mar 18;6:16
pubmed: 32194981
Cell. 2020 Jul 23;182(2):429-446.e14
pubmed: 32526206
Int J Mol Sci. 2021 Jan 28;22(3):
pubmed: 33525682
Nature. 2020 May;581(7807):221-224
pubmed: 32225175
Lancet. 2020 Feb 22;395(10224):e39
pubmed: 32035510
Stem Cell Reports. 2021 Mar 9;16(3):412-418
pubmed: 33691146
Cell Stem Cell. 2016 May 5;18(5):587-90
pubmed: 26952870
Cell. 2016 May 19;165(5):1238-1254
pubmed: 27118425
Am J Pathol. 2012 Feb;180(2):599-607
pubmed: 22189618
Clin Microbiol Rev. 2021 Jan 13;34(2):
pubmed: 33441314
Mol Cells. 2021 Jun 30;44(6):377-383
pubmed: 34187969
Trends Pharmacol Sci. 2020 Aug;41(8):513-517
pubmed: 32553545
Science. 2016 Sep 23;353(6306):1387-1393
pubmed: 27562956
Nature. 2021 Jan;589(7841):270-275
pubmed: 33116299
Nature. 2021 Nov;599(7883):114-119
pubmed: 34488225
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202

Auteurs

Bang M Tran (BM)

Department of Infectious Diseases, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.

Samantha L Grimley (SL)

Department of Microbiology and Immunology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.

Julie L McAuley (JL)

Department of Microbiology and Immunology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.

Abderrahman Hachani (A)

Department of Microbiology and Immunology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.

Linda Earnest (L)

Department of Microbiology and Immunology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.

Sharon L Wong (SL)

Molecular and Integrative Cystic Fibrosis Research Centre, School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.

Leon Caly (L)

Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.

Julian Druce (J)

Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.

Damian F J Purcell (DFJ)

Department of Microbiology and Immunology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.

David C Jackson (DC)

Department of Microbiology and Immunology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.

Mike Catton (M)

Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.

Cameron J Nowell (CJ)

Imaging, FACS and Analysis Core, Monash Institute of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.

Laura Leonie (L)

Melbourne Histology Platform, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia.

Georgia Deliyannis (G)

Department of Microbiology and Immunology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.

Shafagh A Waters (SA)

Molecular and Integrative Cystic Fibrosis Research Centre, School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.
School of Women's and Children's Health, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.
Department of Respiratory Medicine, Sydney Children's Hospital, Randwick, NSW 2031, Australia.

Joseph Torresi (J)

Department of Microbiology and Immunology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.

Elizabeth Vincan (E)

Department of Infectious Diseases, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Curtin Medical School, Curtin University, Perth, WA 6102, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH